Salkind Gene 4
4 · Mobiquity Technologies, Inc. · Filed Jul 1, 2024
Insider Transaction Report
Form 4
Salkind Gene
Director10% Owner
Transactions
- Award
Convertible Promissory Notes
2024-06-27+160,000→ 8,035,931 totalExercise: $0.50From: 2024-06-27→ Common Stock (320,000 underlying)
Footnotes (2)
- [F1]Not applicable.
- [F2]The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by a family trust.